Establishment Labs Holdings (ESTA) Other Non-Current Assets (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Other Non-Current Assets came in at $16.1 million in Q1 2026, up 120.41% year-on-year from $7.3 million in Q1 2025, and little changed quarter-over-quarter from $16.1 million in Q4 2025.
Establishment Labs Holdings (ESTA) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $16.1 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 120.41% year-over-year to $16.1 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 120.41% increase from a year earlier, with the FY2025 full-year figure at $16.1 million, up 120.46% from the prior year.
- Other Non-Current Assets was little changed at $16.1 million in Q1 2026 per ESTA's latest filing, from $16.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $16.1 million in Q4 2025 and bottomed at $1.2 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $5.0 million (2024), against an average of $5.3 million.
- Biggest YoY gain for Other Non-Current Assets was 264.5% in 2023; the steepest drop was 0.55% in 2023.
- Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then surged by 264.5% to $4.7 million in 2023, then soared by 55.53% to $7.3 million in 2024, then soared by 120.46% to $16.1 million in 2025, then declined by 0.05% to $16.1 million in 2026.
- Per Business Quant, the three latest ESTA Other Non-Current Assets figures stand at $16.1 million (Q1 2026), $16.1 million (Q4 2025), and $6.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 16.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.11 Mn |
| Dec 31, 2025 | 16.12 Mn |
| Sep 30, 2025 | 6.94 Mn |
| Jun 30, 2025 | 6.94 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 7.31 Mn |
| Sep 30, 2024 | 5.21 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 5.01 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 558,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 617,000.00 |